These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 29437625)

  • 41. Evaluating the Relationship between Vancomycin Trough Concentration and 24-Hour Area under the Concentration-Time Curve in Neonates.
    Tseng SH; Lim CP; Chen Q; Tang CC; Kong ST; Ho PC
    Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29358290
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cefotaxime kinetics in plasma and synovial fluid following intravenous administration in horses.
    Orsini JA; Moate PJ; Engiles J; Norman T; Poppenga R; Benson CE; Boston RC
    J Vet Pharmacol Ther; 2004 Oct; 27(5):293-8. PubMed ID: 15500566
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dexmedetomidine Pharmacology in Neonates and Infants After Open Heart Surgery.
    Su F; Gastonguay MR; Nicolson SC; DiLiberto M; Ocampo-Pelland A; Zuppa AF
    Anesth Analg; 2016 May; 122(5):1556-66. PubMed ID: 26218862
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pilot Study of the Pharmacokinetics of Cefotaxime in Critically Ill Patients with Acute Kidney Injury Treated with Continuous Renal Replacement Therapy.
    Koedijk JB; Valk-Swinkels CG; Rijpstra TA; Touw DJ; Mulder PG; van der Voort PH; van 't Veer NE; van der Meer NJ
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3587-90. PubMed ID: 27021325
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Assessment of optimal initial dosing regimen with vancomycin pharmacokinetics model in very low birth weight neonates.
    Kato H; Hagihara M; Nishiyama N; Koizumi Y; Mikamo H; Matsuura K; Yamagishi Y
    J Infect Chemother; 2017 Mar; 23(3):154-160. PubMed ID: 28017667
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Study on intravenous drip infusion therapy of cefotiam in neonates and infants].
    Nakazawa S; Sato H; Hirama Y; Narita A; Nakazawa S; Suzuki H; Chikaoka H; Tazoe K
    Jpn J Antibiot; 1986 Sep; 39(9):2399-406. PubMed ID: 3467083
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment of severe neonatal infections with cefotaxime. Efficacy and pharmacokinetics.
    Kafetzis DA; Brater DC; Kapiki AN; Papas CV; Dellagrammaticas H; Papadatos CJ
    J Pediatr; 1982 Mar; 100(3):483-9. PubMed ID: 6278118
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Microdialysis study of cefotaxime cerebral distribution in patients with acute brain injury.
    Dahyot-Fizelier C; Frasca D; Grégoire N; Adier C; Mimoz O; Debaene B; Couet W; Marchand S
    Antimicrob Agents Chemother; 2013 Jun; 57(6):2738-42. PubMed ID: 23571541
    [TBL] [Abstract][Full Text] [Related]  

  • 49. High-Dose Micafungin for Preterm Neonates and Infants with Invasive and Central Nervous System Candidiasis.
    Auriti C; Falcone M; Ronchetti MP; Goffredo BM; Cairoli S; Crisafulli R; Piersigilli F; Corsetti T; Dotta A; Pai MP
    Antimicrob Agents Chemother; 2016 Dec; 60(12):7333-7339. PubMed ID: 27697761
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Penetration of cefotiam dihydrochloride into cerebrospinal fluid (author's transl)].
    Kojima T; Waga S; Morikawa A; Okada M; Furuno M; Shimizu T
    Jpn J Antibiot; 1982 Apr; 35(4):1063-7. PubMed ID: 6285024
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of vancomycin dosing regimens in preterm and term neonates using Monte Carlo simulations.
    Mehrotra N; Tang L; Phelps SJ; Meibohm B
    Pharmacotherapy; 2012 May; 32(5):408-19. PubMed ID: 22488303
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The contribution of pharmacokinetic-pharmacodynamic modelling with Monte Carlo simulation to the development of susceptibility breakpoints for Neisseria meningitidis.
    Burgess DS; Frei CR; Lewis Ii JS; Fiebelkorn KR; Jorgensen JH
    Clin Microbiol Infect; 2007 Jan; 13(1):33-9. PubMed ID: 17184285
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacokinetics of penicillin G in infants with a gestational age of less than 32 weeks.
    Muller AE; DeJongh J; Bult Y; Goessens WH; Mouton JW; Danhof M; van den Anker JN
    Antimicrob Agents Chemother; 2007 Oct; 51(10):3720-5. PubMed ID: 17646418
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Use of population pharmacokinetic modeling and Monte Carlo simulation to describe the pharmacodynamic profile of cefditoren in plasma and epithelial lining fluid.
    Lodise TP; Kinzig-Schippers M; Drusano GL; Loos U; Vogel F; Bulitta J; Hinder M; Sörgel F
    Antimicrob Agents Chemother; 2008 Jun; 52(6):1945-51. PubMed ID: 17485507
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Population pharmacokinetics and dosing of flucloxacillin in preterm and term neonates.
    Pullen J; de Rozario L; Stolk LM; Degraeuwe PL; van Tiel FH; Zimmermann LJ
    Ther Drug Monit; 2006 Jun; 28(3):351-8. PubMed ID: 16778719
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Physiologically-Based Pharmacokinetic Modeling of Fluconazole Using Plasma and Cerebrospinal Fluid Samples From Preterm and Term Infants.
    Gerhart JG; Watt KM; Edginton A; Wade KC; Salerno SN; Benjamin DK; Smith PB; Hornik CP; Cohen-Wolkowiez M; Duara S; Ross A; Shattuck K; Stewart DL; Neu N; Gonzalez D;
    CPT Pharmacometrics Syst Pharmacol; 2019 Jul; 8(7):500-510. PubMed ID: 31087536
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Population Pharmacokinetics and Dosing Regimen Optimization of Meropenem in Cerebrospinal Fluid and Plasma in Patients with Meningitis after Neurosurgery.
    Lu C; Zhang Y; Chen M; Zhong P; Chen Y; Yu J; Wu X; Wu J; Zhang J
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6619-6625. PubMed ID: 27572392
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Interleukin-6 and tumor necrosis factor-alpha levels in plasma and cerebrospinal fluid of term newborn infants with hypoxic-ischemic encephalopathy.
    Silveira RC; Procianoy RS
    J Pediatr; 2003 Nov; 143(5):625-9. PubMed ID: 14615734
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Serum concentrations of cefotaxime and its metabolite desacetyl-cefotaxime in infants and children during continuous infusion.
    Bertels RA; Semmekrot BA; Gerrits GP; Mouton JW
    Infection; 2008 Oct; 36(5):415-20. PubMed ID: 18791659
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Penetration of cefotaxime into human cerebrospinal fluid].
    Asahi S; Kagawa M
    Jpn J Antibiot; 1985 Jun; 38(6):1680-4. PubMed ID: 4046180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.